Cited by 357Cervical Cancer and HPV ResearchWomen's cancer prevention and managementEndometrial and Cervical Cancer Treatments

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

The IARC Perspective on Cervical Cancer Screening

Open access

Bouvard, Véronique, Wentzensen, Nicolas, Mackie, Anne, Berkhof, Johannes, Brotherton, Julia, Giorgi-Rossi, Paolo, Kupets, Rachel, Smith, Robert, Arrossi, Silvina, Bendahhou, Karima, Canfell, Karen, Chirenje, Z. Mike, Chung, Michael H., del Pino, Marta, de Sanjosé, Silvia, Elfström, Miriam, Franco, Eduardo L., Hamashima, Chisato, Hamers, Françoise F., Herrington, C. Simon, Murillo, Raúl, Sangrajrang, Suleeporn, Sankaranarayanan, Rengaswamy, Saraiya, Mona, Schiffman, Mark, Zhao, Fanghui, Arbyn, Marc, Prendiville, Walter, Indave Ruiz, Blanca I., Mosquera-Metcalfe, Isabel, Lauby-Secretan, Béatrice·2021·New England Journal of Medicine

DOI 10.1056/nejmsr2030640PMC PMC12125667

Open this paper in CoChat — free account Open PDF

Abstract

In May 2018, the World Health Organization (WHO) called for a global initiative to eliminate cervical cancer as a public health problem. To achieve this goal, global scale-up of effective vaccination against the human papillomavirus (HPV) as well as screening for and treatment of cervical cancer are required. Cervical cancer screening was evaluated in 2005 by the International Agency for Research on Cancer (IARC) Handbooks program,1 and a reevaluation was deemed to be timely given the major advances in the field since then. The new handbook provides updated evaluations of the effectiveness of screening methods, which were used as a basis for the update of the WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention.2 We convened an IARC Working Group of 27 scientists from 20 countries to assess the evidence on the current approaches to and technologies used in cervical cancer screening with the use of the newly updated Handbooks Preamble3 (Fig. 1) and Table 1).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmsr2030640

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30482-6 · Cited by 4,465
Self-citation
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O. J., & Bray, F. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.07.005 · Cited by 2,479
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Self-citation
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278
Self-citation
Estimates of the global burden of cervical cancer associated with HIV
Stelzle, D., Tanaka, L. F., Lee, K. K., Khalil, A. I., Baussano, I., Shah, A. S. V., McAllister, D., Gottlieb, S. L., Klug, S. J., Winkler, A. S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30459-9 · Cited by 1,004
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citation
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities
Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050132 · Cited by 976
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 955
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
Self-citation
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
Arbyn, M., Smith, S. B., Temin, S., Sultana, F., & Castle, P. (2018) · BMJ · doi:10.1136/bmj.k4823 · Cited by 851
Self-citation
Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797
Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975
Vecchia, C. L., Bosetti, C., Lucchini, F., Bertuccio, P., Negri, E., Boyle, P., & Levi, F. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp530 · Cited by 559
Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial
Sankaranarayanan, R., Esmy, P. O., Rajkumar, R., Muwonge, R., Swaminathan, R., Shanthakumari, S., Fayette, J.-M., & Cherian, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61195-7 · Cited by 549
Self-citation
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Rijkaart, D., Berkhof, J. H., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W. J., Heideman, D. A. M., Kenter, G. G., Cuzick, J. M., Snijders, P. J. F., & Meijer, C. J. L. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 530
Self-citation
Screening for cervical cancer: a systematic review and meta-analysis
Peirson, L., Fitzpatrick‐Lewis, D., Ciliska, D. K., & Warren, R. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-35 · Cited by 467
Screen-and-Treat Approaches for Cervical Cancer Prevention in Low-Resource Settings: A Randomized Controlled Trial
Denny, L., Kuhn, L., De Souza, M., Pollack, A. E., Dupree, W., & Wright, T. C. (2005) · JAMA · doi:10.1001/jama.294.17.2173 · Cited by 364
Triage of HPV positive women in cervical cancer screening
Wentzensen, N., SCHIFFMAN, M. H., Palmer, T. J., & Arbyn, M. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.11.015 · Cited by 355
Self-citation
Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial
Ronco, G., Segnan, N., Rossi, P. G., Zappa, M., Casadei, G. P., Carozzi, F., Palma, P. D., Mistro, A. D., Folicaldi, S., Gillio‐Tos, A., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj209 · Cited by 312
Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P., Mistro, A. D., Gillio‐Tos, A., Minucci, D., Naldoni, C., Rizzolo, R., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn065 · Cited by 306
Self-citation
Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis
Kelly, H. A., Weiss, H. A., Benavente, Y., de Sanjosé, S., Mayaud, P., Qiao, Y., Feng, R., Vuyst, H. D., Tenet, V., Jaquet, A., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30149-2 · Cited by 301
Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Kyrgiou, M., Athanasiou, A., Kalliala, I. E. J., Paraskevaidi, M., Mitra, A., Martin‐Hirsch, P. L., Arbyn, M., Bennett, P. R., & Paraskevaidis, E. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012847 · Cited by 294
Self-citation
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months
Ogilvie, G. S., van Niekerk, D., Krajden, M., Smith, L., Cook, D. A., Gondara, L., Ceballos, K. M., Quinlan, D., Lee, M. H., Martin, R. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.7464 · Cited by 283
Self-citation
Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial
Ronco, G., Cuzick, J. M., Pierotti, P., Cariaggi, M. P., Palma, P. D., Naldoni, C., Ghiringhello, B., Rossi, P. G., Minucci, D., Parisio, F., et al. (2007) · BMJ · doi:10.1136/bmj.39196.740995.be · Cited by 278
Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test
Gage, J. C., SCHIFFMAN, M. H., Katki, H. A., Castle, P., Fetterman, B. J., Wentzensen, N., Poitras, N. E., Lorey, T. S., Cheung, L. C., & Kinney, W. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju153 · Cited by 269
Self-citation
Comparison of Liquid-Based Cytology With Conventional Cytology for Detection of Cervical Cancer Precursors
Siebers, A. G., Klinkhamer, P. J. J. M., Grefte, J. M. M., Massuger, L. F. A. G., Vedder, J. E. M., Beijers-Broos, A., Bulten, J., & Arbyn, M. (2009) · JAMA · doi:10.1001/jama.2009.1569 · Cited by 257
Self-citation
The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis
Nelson, E. J., Maynard, B. R., Loux, T., Fatla, J., Gordon, R., & Arnold, L. D. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052609 · Cited by 252
Effect of VIA Screening by Primary Health Workers: Randomized Controlled Study in Mumbai, India
Shastri, S., Mittra, I., Mishra, G. A., Gupta, S. D., Dikshit, R. P., Singh, S., & Badwe, R. A. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju009 · Cited by 249
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial
Polman, N. J., Ebisch, R. M. F., Heideman, D. A. M., Melchers, W. J. G., Bekkers, R. L. M., Molijn, A. C., Meijer, C. J. L. M., Quint, W. G. V., Snijders, P. J. F., Massuger, L. F. A. G., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30763-0 · Cited by 232
Self-citation
Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial
Arrossi, S., Thouyaret, L., Herrero, R., Campanera, A., Magdaleno, A., Cuberli, M., Barletta, P., Laudi, R., & Orellana, L. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70354-7 · Cited by 217
Self-citation
A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India
Sankaranarayanan, R., Nene, B. M., Dinshaw, K. A., Mahe, C., Jayant, K., Shastri, S. S., Malvi, S. G., Chinoy, R., Kelkar, R., Budukh, A. M., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21050 · Cited by 206
Self-citation
ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
Kitchener, H. C., Almonte, M., Gilham, C., Dowie, R., Stoykova, B., Sargent, A., Roberts, C., Desai, M., & Peto, J. (2009) · Health Technology Assessment · doi:10.3310/hta13510 · Cited by 186
Human Papillomavirus–Based Cervical Cancer Prevention: Long-term Results of a Randomized Screening Trial
Denny, L., Kuhn, L., Hu, C.-C., Tsai, W.-Y., & Wright, T. C. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq342 · Cited by 177
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening
SCHIFFMAN, M. H., Kinney, W., Cheung, L. C., Gage, J. C., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Wentzensen, N., Befano, B., Schussler, J. E., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx225 · Cited by 165
Self-citation
Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
Elfstrom, K. M., Smelov, V., Johansson, A. L. V., Eklund, C., Naucler, P., Arnheim-Dahlstrom, L., & Dillner, J. (2014) · BMJ · doi:10.1136/bmj.g130 · Cited by 142
Self-citation
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Dijkstra, M. G., van Zummeren, M., Rozendaal, L., van Kemenade, F. J., Helmerhorst, T. J. M., Snijders, P. J. F., Meijer, C. J. L. M., & Berkhof, J. H. (2016) · BMJ · doi:10.1136/bmj.i4924 · Cited by 123
Self-citation
Validation of Cervical Cancer Screening Methods in HIV Positive Women from Johannesburg South Africa
Firnhaber, C. S., Mayisela, N., Mao, L., Williams, S. T., Swarts, A., Faesen, M., Levin, S., Michelow, P., Omar, T., Hudgens, M. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053494 · Cited by 117
Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland
Leinonen, M. K., Nieminen, P., Lönnberg, S., Malila, N. K., Hakama, M., Pokhrel, A., Laurila, P., Tarkkanen, J., & Anttila, A. (2012) · BMJ · doi:10.1136/bmj.e7789 · Cited by 115
Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program
Strander, B., Andersson‐Ellström, A., Milsom, I., Rådberg, T., & Ryd, W. (2007) · Cancer · doi:10.1002/cncr.22953 · Cited by 113
Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
Canfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J. M. L., Gertig, D. M., Jennett, C. J., Farnsworth, A., Tan, J., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002388 · Cited by 100
Self-citation
Does Liquid-Based Technology Really Improve Detection of Cervical Neoplasia?
Obwegeser, J. H., & Brack, S. (2001) · Acta Cytologica · doi:10.1159/000328292 · Cited by 95
Direct comparison of liquid‐based and conventional cytology in a South African screening trial
Taylor, S., Kuhn, L., Dupree, W. B., Denny, L. E., Souza, M. D., & Wright, T. C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21434 · Cited by 84
Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after retrospective cohort study
Arrossi, S., Paolino, M., Laudi, R., Gago, J. E., Campanera, A., Marín, O., Falcón, C., Serra, V., Herrero, R., & Thouyaret, L. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30048-8 · Cited by 78
Self-citation
Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India
Basu, P. S., Mittal, S., Banerjee, D., Singh, P., Panda, C. K., Dutta, S., Mandal, R., Das, P., Biswas, J., Muwonge, R., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29458 · Cited by 76
Self-citation
Cervical cancer risk in women living with HIV across four continents: A multicohort study
Rohner, E., Bütikofer, L., Schmidlin, K., Muchengeti, M. M., Maskew, M., Giddy, J., Taghavi, K., Moore, R. D., Goedert, J. J., Gill, M. J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32260 · Cited by 76
Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening
Sargent, A., Fletcher, S., Bray, K., Kitchener, H. C., & Crosbie, E. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025388 · Cited by 75
A randomised comparison of SurePath liquid‐based cytology and conventional smear cytology in a colposcopy clinic setting
Sykes, P. H., Harker, D., Miller, A., Whitehead, M. R., Neal, H., Wells, J., & Peddie, D. J. (2008) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01865.x · Cited by 48
Evaluation of cervical screening in rural North India
Bhatla, N., Gulati, A., Mathur, S. R., Rani, S., Krishnan, A., Muwonge, R., & Sankaranarayanan, R. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2008.12.010 · Cited by 48
Self-citation
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany
Iftner, T., Neis, K.-J., Castañón, A., Landy, R., Holz, B., Woll-Herrmann, A., Iftner, A., Staebler, A., Wallwiener, D. R., von Weyhern, C. H., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01177-18 · Cited by 40
Diagnostic accuracy of cervical cancer screening and screening–triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study
Kelly, H. A., Chikandiwa, A. T., Sawadogo, B., Gilham, C., Michelow, P. M., Lompo, O., Omar, T., Zan, S., Magooa, P., Segondy, M., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003528 · Cited by 40
A randomized trial comparing conventional cytology to liquid‐based cytology and computer assistance
Klug, S. J., Neis, K. J., Harlfinger, W., Malter, A., König, J., Spieth, S., Brinkmann‐Smetanay, F., Kommoss, F., Weyer, V., & Ikenberg, H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27955 · Cited by 37
HPV‐mRNA and HPV‐DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri
Forslund, O., Elfström, K. M., Lamin, H., & Dillner, J. (2018) · International Journal of Cancer · doi:10.1002/ijc.31819 · Cited by 34
Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study
El‐Zein, M., Bouten, S., Louvanto, K., Gilbert, L., Gotlieb, W. H., Hemmings, R., Behr, M. A., & Franco, E. L. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.04.004 · Cited by 30
Self-citation
Having a Pap smear, quality of life before and after cervical screening: a questionnaire study
Korfage, I., van Ballegooijen, M., Wauben-Spaetgens, B., Looman, C., Habbema, J., & Essink‐Bot, M. (2012) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2012.03344.x · Cited by 29
Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial
Cook, D. A., Smith, L., Law, J. H., Mei, W., Gondara, L., van Niekerk, D. J., Ceballos, K. M., Jang, D., Chernesky, M., Franco, E. L., et al. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.09.004 · Cited by 29
Self-citation
Primary HPV testing with cytology versus cytology alone in cervical screening—A prospective randomized controlled trial with two rounds of screening in a Chinese population
Chan, K. K. L., Liu, S. S., Wei, N., Ngu, S., Chu, M. M. Y., Tse, K. Y., Lau, L. S. K., Cheung, A., & Ngan, H. (2020) · International Journal of Cancer · doi:10.1002/ijc.32861 · Cited by 26
Psycho-social impact of positive human papillomavirus testing in Jujuy, Argentina results from the Psycho-Estampa study
Arrossi, S., Almonte, M., Herrero, R., Gago, J. E., Antelo, V. S., Szwarc, L., Thouyaret, L., Paolino, M., & Wiesner, C. (2020) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2020.101070 · Cited by 25
Self-citation
Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus
Luckett, R. L., Mogowa, N., Li, H. J., Erlinger, A. L., Hacker, M. R., Esselen, K. M., Feldman, S., Shapiro, R., Morroni, C., & Ramogola‐Masire, D. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003496 · Cited by 25
Risk of CIN2 or more severe lesions after negative HPV‐mRNA E6/E7 overexpression assay and after negative HPV‐DNA test: Concurrent cohorts with a 5‐year follow‐up
Zorzi, M., Mistro, A. D., Rossi, P. G., Laurino, L., Battagello, J., Lorio, M., Soldà, M., Gabellotti, E. M., Maran, M., Cin, A. D., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32695 · Cited by 16
Comparison of the Conventional Cervical Smear and Liquid-Based Cytology
Maccallini, V., Angeloni, C., Caraceni, D., Fortunato, C., Venditti, M. A., Gabriele, G. D., Antonelli, C., Lattanzi, A., Puliti, D., Ciatto, S., et al. (2008) · Acta Cytologica · doi:10.1159/000325599 · Cited by 16
Effectiveness of cervical cancer screening at age 65 — A register-based cohort study
Pankakoski, M., Anttila, A., Sarkeala, T. M., & Heinävaara, S. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214486 · Cited by 16
[Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao, Y., Dai, Y., Dang, L., Kong, L. H., Zhang, Y., Feng, R., Qiao, Y., & Lang, J. (2018) · PubMed · doi:10.3760/cma.j.issn.0253-3766.2018.10.008 · Cited by 16
Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China
Zhang, L., Xu, X., Hu, S., Chen, F., Zhang, X., Pan, Q., Zhang, W., Feng, R., Dong, L., Zhang, Q., et al. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.09.012 · Cited by 15
Self-citation
Optional screening strategies for cervical cancer using standalone tests and their combinations among low- and medium-income populations in Latin America and Eastern Europe
Sarian, L. O., Derchain, S., Shabalova, I. P., Tatti, S., Naud, P., Longatto‐Filho, A., Syrjänen, S., & Syrjänen, K. J. (2010) · Journal of Medical Screening · doi:10.1258/jms.2010.010016 · Cited by 13
Adjunct screening of cervical or vaginal samples using careHPV testing with Pap and aided visual inspection for detecting high-grade cervical intraepithelial neoplasia
Asthana, S., & Labani, S. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.11.006 · Cited by 13
An on-going study of three different cervical cancer screening strategies based on primary healthcare facilities in Beijing China
Han, L., Chang, X., Song, P., Gao, L., Zhang, Y., An, L., & Shen, J. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.09.003 · Cited by 9

Research works printed but not linked: 3

Cervix cancer screening. IARC handbooks of cancer prevention. Vol. 10. Lyon France: International Agency for Research on Cancer 2005 (https://publications.iarc.fr/380).
Serrano B Roura E Guijarro P et al. National cervical cancer screening programs and coverage worldwide. Presented at the 33rd International Papillomavirus Conference virtual July 20–24 2020.
Cervical cancer screening. IARC handbooks of cancer prevention. Vol. 18. Lyon France: International Agency for Research on Cancer (in press).

Sorted by citations

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., Arbyn, M., Basu, P., Bray, F., & Vaccarella, S. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00501-0 · Cited by 1,616
Self-citation
Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis
Bruni, L., Serrano, B., Roura, E., Alemany, L., Cowan, M., Herrero, R., Poljak, M., Murillo, R., Broutet, N., Riley, L. M., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00241-8 · Cited by 558
Self-citation
Cervical Cancer Screening
Perkins, R. B., Wentzensen, N., Guido, R. S., & Schiffman, M. (2023) · JAMA · doi:10.1001/jama.2023.13174 · Cited by 553
Self-citation
Worldwide use of HPV self-sampling for cervical cancer screening
Serrano, B., Ibáñez, R., Robles, C., Peremiquel‐Trillas, P., de Sanjosé, S., & Bruni, L. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106900 · Cited by 298
IARC Perspective on Oral Cancer Prevention
Bouvard, V., Nethan, S. T., Singh, D., Warnakulasuriya, S., Mehrotra, R., Chaturvedi, A. K., Chen, T. H.-H., Ayo-Yusuf, O. A., Gupta, P. C., Kerr, A. R., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmsr2210097 · Cited by 166
Self-citation

See all 357

Authors: Bouvard, V., Wentzensen, N., Mackie, A., Berkhof, J., Brotherton, J., Giorgi-Rossi, P., Kupets, R., Smith, R., Arrossi, S., Bendahhou, K., Canfell, K., Chirenje, Z. M., Chung, M. H., del Pino, M., de Sanjosé, S., Elfström, M., Franco, E. L., Hamashima, C., Hamers, F. F., Herrington, C. S., Murillo, R., Sangrajrang, S., Sankaranarayanan, R., Saraiya, M., Schiffman, M., Zhao, F., Arbyn, M., Prendiville, W., Indave Ruiz, B. I., Mosquera-Metcalfe, I., & Lauby-Secretan, B.
Affiliations: The University of Sydney (AU)
From the International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.M., B.L.-S.), and the National Public Health Agency, Saint-Maurice (F.F.H.) — both in France; the National Cancer Institute, Rockville, MD (N.W., M. Schiffman); Public Health England and Screening, London (A.M.); Amsterdam University Medical Centers, Amsterdam (J. Berkhof); VCS Foundation, Melbourne, VIC (J. Brotherton), Australia; Azienda Unità Sanitaria Locale — IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.R.); the University of Toronto, Toronto (R.K.); the American Cancer Society (R. Smith), Emory University (M.H.C.), and the Centers for Disease Control and Prevention (M. Saraiya) — all in Atlanta; the Center for the Study of the State and Society, and the National Scientific and Technical Research Council — both in Buenos Aires (S.A.); the Casablanca Cancer Registry, Casablanca, Morocco (K.B.); The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King’s Cross, NSW, Austra...
ORCID: Wentzensen, Nicolas
Berkhof, Johannes
Brotherton, Julia
Arrossi, Silvina
Chirenje, Z. Mike
Herrington, C. Simon
Murillo, Raúl
Sankaranarayanan, Rengaswamy
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2021-11-11
Volume: 385
Issue: 20
Pages: 1908-1918
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmsr2030640
PMC: PMC12125667
OpenAlex: W3213089363
Cited by: 357
References: 65
Citations by year: 2026: 63 · 2025: 86 · 2024: 98 · 2023: 77 · 2022: 32 · 2021: 1
FWCI: 37.47
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
PubMed Central (acceptedVersion)
Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
Institutional Repositories DataBase (IRDB) (submittedVersion)
Minerva Access (University of Melbourne) (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: World Health Organization
National Institutes of Health
Japan Society for the Promotion of Science (20K10331)
National Cancer Institute (ZIACP010124)
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords: cervical cancer screening, cervical cancer elimination, screening effectiveness, HPV vaccination, WHO guidelines, cervical cancer prevention, cervical cancer treatment
MeSH terms: Uterine Cervical Neoplasms, Female, Humans, Mass Screening, World Health Organization, Practice Guidelines as Topic, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The IARC Perspective on Cervical Cancer Screening

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks